Dr. Alfredo C. Rivadeneira, MD

Dr. Rivadeneira practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Dr. Rivadeneira's NPI, 1760543896, was assigned on December 13, 2006. Dr. Rivadeneira graduated from Universidad Nacional de Cordoba in 1990.

Dr. Rivadeneira's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Dr. Rivadeneira's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. Dr. Rivadeneira is also affiliated with UNC Health Rex. The medical group on file is UNC Faculty Physicians. Dmand AI also links Dr. Rivadeneira to 1 more therapy and rehab clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rivadeneira practices, 3 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Rivadeneira's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Rivadeneira is board certified in rheumatology by the American Board of Internal Medicine. Dr. Rivadeneira has a license on file in North Carolina.

Dmand AI lists arthritis, fibromyalgia and chronic pain, gout, joint arthropathy, joint pain, lupus, muscle pain, fibromyalgia, and limb pain and osteoporosis among the conditions Dr. Rivadeneira treats.

CMS data shows 311 Medicare services from Dr. Rivadeneira across 3 procedure codes in 2024, for 141 Medicare patients. Medicare paid $11,888 for them. Every service was in an office.

CMS counts 141 Medicare patients who saw Dr. Rivadeneira in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have arthritis, and 67% have high blood pressure. 16% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rivadeneira's median patient age at 69, with 71% women.

In 2024, Dr. Rivadeneira wrote 1,744 Medicare Part D claims for 191 patients. 80% of them were for generic drugs. CMS names the drug for 1,559 of them, across 39 drugs with 11 or more claims each, at $1,484,547 in total drug cost. In 2023, CMS named 1,703 claims across 36 drugs.

Dr. Rivadeneira accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rivadeneira as offering telehealth.

Dmand AI links 4 papers to Dr. Rivadeneira, published from 2016 to 2024. 2024 was the busiest year, with 2. Dr. Rivadeneira's most frequent co-authors are Daniel S. Reuland, MD, Irene Blanco, MD and Mauricio G. Cohen, MD.

CMS Open Payments shows 3 general payments to Dr. Rivadeneira from 2 drug and device companies from 2019 to 2023. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $122.

Dmand AI lists 2 awards for Dr. Rivadeneira, most recently CMS Stage 1 2012 in 2012.

Dr. Rivadeneira graduated from Universidad Nacional de Cordoba in 1990. Dr. Rivadeneira is a member of ACR.

Dr. Rivadeneira is in network with 18 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.